ReviewNanoscale advances2025
Bimetallic nanoparticles as pioneering eco-friendly catalysts for remediation of pharmaceuticals and personal care products (PPCPs).
Review in Nanoscale advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Tracking Out-Of-Equilibrium Growth of Bimetallic Nanoalloys Using Deep Learning and X-ray Scattering.ACS nano · 2026Article
- Article
- A magnetically recoverable MOF-derived nanocatalyst for the efficient synthesis of organic heterocycles with pharmaceutical and agricultural properties.Molecular diversity · 2026Article
- Green Nanoparticles for Enhanced Electrochemical Monitoring of Pharmaceutical Contaminants: Comparative Investigation Between Monometallic and Bimetallic Nanoparticles.Micromachines · 2025Article
- Nanomaterials for Persistent Organic Pollutants Decontamination in Water: Mechanisms, Challenges, and Future Perspectives.Nanomaterials (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The persistent presence of Pharmaceuticals and Personal Care Products (PPCPs) in aquatic environments poses a significant risk to both human health and ecosystems, with conventional water treatment methods often unable to effectively remove these contaminants. Recent research has identified bimetallic nanoparticles as a promising and eco-friendly solution for PPCP remediation, owing to their enhanced catalytic properties and the synergistic effects between the metals. This review critically examines the synthesis, characterization, and application of bimetallic nanoparticles for the degradation of PPCPs in water. Key synthetic approaches, particularly green synthesis methods, are explored, emphasizing their ability to control nanoparticle morphology, size, and composition. We highlight the novel catalytic mechanisms employed by bimetallic nanoparticles, including electron transfer, surface reactions, and adsorption processes, which contribute to efficient PPCP removal. Furthermore, the influence of critical factors such as nanoparticle size, composition, and surface functionalization on catalytic efficiency is analyzed. Key findings include the superior performance of bimetallic nanoparticles over monometallic counterparts, with specific emphasis on their ability to degrade a wide range of PPCPs under mild conditions. However, challenges such as scalability, stability, and environmental impact remain. This review also provides insights into the future directions for bimetallic nanoparticle development, stressing the importance of interdisciplinary research and collaborative efforts to optimize their design for large-scale, sustainable water treatment applications. Overall, this work offers a comprehensive understanding of how bimetallic nanoparticles can be optimized for sustainable water treatment solutions, highlighting their potential to mitigate the adverse effects of PPCPs on both ecosystems and public health.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.